SGLT2‐Inhibition reverts urinary peptide changes associated with severe COVID‐19: An in‐silico proof‐of‐principle of proteomics‐based drug repurposing
Journal article published in 2021 by
Agnieszka Latosinska,
Justyna Siwy 
,
David Z. Cherney,
Bruce A. Perkins,
Harald Mischak,
Joachim Beige
,
David Z. Cherney,
Bruce A. Perkins,
Harald Mischak,
Joachim Beige
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 